Union Institute & University has named Kim C Byas, Sr, PhD, MPH, FACHE to head the new Master of Science in Health Care Leadership program, it was reported yesterday.
Dr Byas has served around 40 years in various health care settings including as regional executive with the American Hospital Association where he works with hospitals on federal advocacy, health care system transformation, and health policy. Prior to accepting this position, he served for more than 16 years as the regional executive with the American Hospital Association, working with hospitals on federal advocacy, health care system transformation, and health policy. His other roles have included, interim president/CEO, Institute for Diversity in Health Management; CEO of Kailo Alliance, a health care strategic consulting company; executive director of a multispecialty physicians group; and as adjunct faculty with DePaul University's Master in Public Administration program and Loyola University of Chicago's MBA in Healthcare.
Dr Byas received his PhD. with a concentration in Ethical and Creative Leadership from Union Institute & University in Cincinnati; Master in Public Health from The University of Michigan, Ann Arbor; and BA from Wittenberg University, Springfield, Ohio. He is a fellow of the American College of Healthcare Executives.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer